G. Pagani
United Hospitals
11 Papers
48 Citations
G. Pagani is an academic researcher from United Hospitals. The author has contributed to research in topics: Acromegaly & Bromocriptine. The author has an hindex of 8, co-authored 11 publications.
Chat about Author
Papers
Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients
Ioana Lancranjan,C. Bruns,Peter Grass,Philippe Jaquet,Jak Jervell,P. Kendall-Taylor,S. W. J. Lamberts,Peter Marbach,Hans Ørskov,G. Pagani,Michael C. Sheppard,L. Simionescu +11 more
TL;DR: Due to its excellent efficacy, good tolerability, convenience of administration, and acceptability by patients, Sandostatin LAR is considered a promising therapeutic tool in the management of acromegalic patients.
152
Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients
Ioana Lancranjan,C. Bruns,Peter Grass,Philippe Jaquet,Jak Jervell,P. Kendall-Taylor,S. W. J. Lamberts,Peter Marbach,Hans Ørskov,G. Pagani,Michael C. Sheppard,L. Simionescu +11 more
TL;DR: A trend toward progressive suppression of GH secretion and insulin-like growth factor-I (IGF-I) serum concentrations was noted during long-term treatment with repeated (up to seven) IM injections of Sandostatin LAR®.
100
Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients
Roberto Attanasio,A. Mainolfi,Franco Grimaldi,Renato Cozzi,M. Montini,Chiara Carzaniga,Silvia Grottoli,L. Cortesi,M Albizzi,R M Testa,Letizia Maria Fatti,D De Giorgio,Carla Scaroni,F. Cavagnini,Paola Loli,G. Pagani,Ezio Ghigo +16 more
TL;DR: Obesity and dyslipidemia appear to play a major role in the occurrence of GS in acromegalic patients on SA treatment, and may occur at any time, but are seldom symptomatic or prompt acute surgery.
56
Treatment of acromegaly with SS analogues: Should GH and IGF-I target levels be lowered to assert a tight control of the disease?
Renato Cozzi,Roberto Attanasio,Silvia Grottoli,G. Pagani,Paola Loli,Valentina Gasco,Alberto M Pedroncelli,M. Montini,Ezio Ghigo +8 more
TL;DR: In acromegalic patients on SA treatment, GH and IGF-I levels are often not concordant, and in addition to age, sex is to be taken into account in the evaluation of hormonal targets.
16